New York, June 14, 2026, 16:03 EDT
- UiPath last traded at $10.55 on Friday, down about 1%, with volume near 40.8 million shares.
- The company’s fiscal first-quarter revenue rose 17% to $418 million, while annual recurring revenue rose 12% to $1.901 billion.
- The next major stock test is whether UiPath can meet its fiscal second-quarter targets and show that AI-driven automation demand is translating into stronger recurring revenue.
UiPath Inc. (NYSE: PATH) heads into the new trading week under pressure after the automation-software stock ended Friday at $10.55, about 0.99% lower, after trading between $10.07 and $10.78. The move matters because PATH remains priced like a company still trying to prove that its artificial intelligence push can revive growth: its market value is about $5.57 billion, and its price-to-earnings ratio, or P/E ratio — the stock price divided by earnings per share — is about 17.6.
The latest company fundamentals were stronger than the stock action suggests. In its fiscal first quarter ended April 30, UiPath reported $418 million in revenue, up 17% year over year, and annual recurring revenue, or ARR — a subscription-software measure that annualizes recurring customer contracts — of $1.901 billion, up 12%. Founder and CEO Daniel Dines called it a “strong start to the fiscal year,” while the company also reported $28 million in GAAP operating income and $130 million in non-GAAP adjusted free cash flow. UiPath, Inc.
The stock-price debate is centered on guidance, not just the most recent beat. UiPath projected fiscal second-quarter revenue of $395 million to $400 million, ARR of $1.929 billion to $1.934 billion as of July 31, and non-GAAP operating income of about $75 million. Non-GAAP results exclude certain accounting costs, commonly including items such as stock-based compensation, so investors use them to judge operating momentum but should not treat them as a full substitute for GAAP profit.
The bull case is that UiPath is no longer just a robotic process automation story. Robotic process automation, or RPA, uses software bots to automate repeatable digital tasks, while UiPath is now positioning itself around “agentic automation,” where AI agents, robots and workflow tools are orchestrated across enterprise processes. Reuters describes the company as focused on agentic automation and orchestration, and UiPath’s own results show cash, cash equivalents and marketable securities of $1.42 billion as of April 30. Reuters UiPath, Inc.
The bear case is that Wall Street is still not convinced growth will accelerate fast enough. Markets Insider’s analyst data show a mixed setup, with 14 buy ratings, 34 neutral ratings and 4 sell ratings, and a median price target of $14.14. Recent listed analyst actions included Needham maintaining a Buy rating with a $15 target, Morgan Stanley maintaining Hold with a $15 target, D.A. Davidson maintaining Hold with a $12 target and Bank of America maintaining Sell with a $13 target.
Competition and AI disruption remain the biggest risks. Earlier this year, Barron’s noted that investors were worried about whether AI demand would materially lift UiPath’s RPA business, while also pointing to competition from larger software players such as Microsoft and ServiceNow. That concern explains why good quarterly numbers may not be enough: investors want proof that agentic automation is producing durable expansion, not just protecting the existing automation base.
The next scheduled company event is UiPath’s annual meeting of stockholders on June 25, but the bigger stock catalyst is likely the fiscal second-quarter update, when investors can compare actual revenue and ARR against the company’s July 31 targets. UiPath is also a member of the S&P MidCap 400, an index designed to track mid-sized U.S. companies, which can support institutional visibility but does not remove execution risk. UiPath, Inc.
At today’s price, UiPath looks fairly valued to risky, rather than clearly cheap. The valuation is not extreme at roughly 3.1 times the midpoint of management’s fiscal 2027 revenue guidance, and the company has real profitability and cash-flow positives. But the analyst mix is mostly neutral, ARR growth is still only in the low teens, and the stock needs evidence that AI agents are expanding customer spending faster. For PATH to become more attractive, investors will likely need to see stronger ARR momentum, stable margins and confirmation that the company’s agentic automation strategy is winning against larger software rivals.
